Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS

ClinicalTrials.gov ID: NCT05996575

Public ClinicalTrials.gov record NCT05996575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 3:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

IMPACT: Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of the proposed observational, multi-site study is to use fNIRS neurophysiological data recorded during a battery of tasks to detect MCI within a cohort consisting of patients and age-matched healthy controls. Furthermore, the investigators aim to explore whether they can measure the severity of MCI symptoms in the patient population. If successful, this approach enables clinicians to track the disease at its source-the brain; possibly allowing for earlier detection of MCI and its progression, and ultimately more efficient interventions.

Study identification

NCT ID
NCT05996575
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Kernel
Industry
Enrollment
133 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2023
Primary completion
Jun 12, 2024
Completion
Jun 12, 2024
Last update posted
Jul 2, 2024

2023 – 2024

United States locations

U.S. sites
6
U.S. states
1
U.S. cities
6
Facility City State ZIP Site status
The Research Center of Southern California Carlsbad California 92011
BrainHealth Solutions Costa Mesa California 92626
The Research Center of Southern California Escondido California 92029
Kernel Los Angeles California 90232
Syrentis Clinical Research Santa Ana California 92705
The Research Center of Southern California Temecula California 92592

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05996575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05996575 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →